InsidersTradesSigma
Follow the 대한약품 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 대한약품 has published 8 public disclosures. Market capitalisation: €155.5bn. The latest transaction was filed on 30 June 2026 (Purchase). Among the most active insiders: 이윤우. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
대한약품 是一家在 XKRX 市场上市的健康和制药公司。它专注于药品制造和分销。